medicare part d plan

Medicare Part D
Prescription Drug Coverage 2026

Find a Medicare Part D prescription drug plan for 2027

Advertisement

Medicare Part D Plans 2026

2027 Medicare Part D plans are now available

Enrollment for 2027 coverage runs October 15 to December 7, 2026. The standard deductible rises to $700 and the out-of-pocket cap rises to $2,400, and the premium stabilization subsidy ends, so many standalone drug plan premiums are changing.

Compare 2027 Part D Plans ➤

Curious about the changes to Medicare Part D Plans in 2026?

2026 brought a higher deductible, a higher out-of-pocket limit, and continued $0 cost-sharing once you reach the catastrophic phase. These rules come from the Inflation Reduction Act’s redesign of the Part D benefit. Here is what applies to your coverage this year.

 

Key Takeaways

  • In 2026, the standard initial deductible for Medicare Part D is $615 and the annual out-of-pocket spending limit is $2,100. For 2027, those rise to $700 and $2,400.
  • The Inflation Reduction Act keeps the $35 monthly cap on covered insulin and $0 cost-sharing for recommended adult vaccines, and negotiated prices for the first 10 selected drugs took effect January 1, 2026.
  • Medicare Advantage plans with built-in drug coverage remain a popular alternative to standalone Prescription Drug Plans, often bundling lower costs and extra benefits.

Overview of Medicare Part D Plans for 2026

 

Overview of Medicare Part D Plans for 2026

Medicare Part D plans changed in 2026 with a focus on keeping medications affordable and costs predictable. The standard initial deductible rose from $590 in 2025 to $615 in 2026, reflecting the ongoing effort to balance costs and benefits within the program.

Beneficiaries also saw a higher out-of-pocket spending limit and continued $0 cost-sharing in the catastrophic phase. These changes come from the Inflation Reduction Act, which redesigned the Part D benefit to lower prescription drug costs.

The following sections break down these updates in more detail.

 

Standard Initial Deductible Increase

In 2026, the Medicare Part D standard initial deductible is $615, up from $590 in 2025. This affects what you pay out of pocket before your plan begins sharing the cost of covered drugs. For 2027, the standard deductible rises again to $700.

Many plans set a lower deductible than the standard amount, and some charge no deductible on lower-tier drugs, so compare plans rather than assuming every plan uses the maximum.

 

Out-of-Pocket Spending Limit Adjustment

The out-of-pocket spending limit for Medicare Part D is $2,100 in 2026, up from $2,000 in 2025. The cap sets a clear ceiling on what you pay for covered Part D drugs in a calendar year.

The 2026 cap took effect January 1, 2026. For 2027, the out-of-pocket cap rises to $2,400.

 

Catastrophic Coverage Phase Benefits

Since January 1, 2024, Medicare beneficiaries pay nothing for covered formulary drugs once they reach the catastrophic coverage phase. In 2026, that point arrives when your out-of-pocket spending reaches $2,100. After that, you have no further cost-sharing for covered drugs for the rest of the calendar year.

 

Key Updates Under the Inflation Reduction Act

 

Key Updates Under Inflation Reduction Act

The Inflation Reduction Act reshaped Medicare Part D in stages, with several protections that continue in 2026. These include a cap on insulin costs, $0 recommended vaccines, and the first negotiated drug prices. Together they provide meaningful financial relief and better access to essential medications.

The Inflation Reduction Act targets high prescription drug costs and expands covered services to positively impact Medicare beneficiaries. The following subsections cover each update.

 

Insulin Cost Cap

Medicare limits covered insulin to $35 per month. The cap began in 2023 and continues in 2026, significantly easing the financial burden for beneficiaries managing diabetes.

The cap applies to insulin covered under Part D and to insulin used with a pump covered under Part B, so insulin users are protected across the Medicare program.

 

Expanded Vaccine Coverage

Adult vaccines recommended by the Advisory Committee on Immunization Practices, such as shingles and Tdap (tetanus, diphtheria and whooping cough), are covered under Part D at no out-of-pocket cost. This protection began in 2023 and continues in 2026, supporting preventive care for more beneficiaries.

 

Drug Price Negotiations

The Medicare Drug Price Negotiation Program put negotiated prices for the first 10 selected Part D drugs into effect on January 1, 2026, with CMS estimating about $1.5 billion in out-of-pocket savings for enrollees. A second group of 15 drugs follows with negotiated prices taking effect in 2027.

The program has faced legal challenges from drug manufacturers, but negotiated prices are in effect. It is a significant step toward lowering prescription drug costs for Medicare beneficiaries.

See plans in your area instantly!

Advertisement

SPEAK WITH A LICENSED INSURANCE AGENT!

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

Enhanced Risk Adjustment Model for Part D

Enhanced Risk Adjustment Model for Part D

The enhanced risk adjustment model for Medicare Part D began phasing in in 2026 and runs over three years. It is how CMS calculates accurate plan bids under the redesigned benefit created by the Inflation Reduction Act, using revised risk corridors and a multiple linear regression methodology to improve payment accuracy.

The model balances potential gains and losses for Part D sponsors, which helps stabilize premiums for beneficiaries. The goal is to keep the Medicare program sustainable without pricing enrollees out of drug coverage.

 

Multiple Linear Regression Methodology

CMS uses a multiple linear regression methodology to calculate normalization factors for risk adjustment in the Part D model. The approach integrates five years of historical fee-for-service risk scores, which improves the accuracy and fairness of payments across the Medicare Part D program.

 

Impact on Premiums and Payments

For 2026, CMS set the Part D base beneficiary premium at $38.99 and the national average monthly bid amount at $239.27. Standalone drug plans also received a uniform $10 per member per month reduction to the base beneficiary premium, down from $15 in 2025.

A second protection caps how much any single plan can raise its total Part D premium year over year. That cap is $50 for 2026, up from $35 in 2025. Together these measures held 2026 standalone drug plan premiums far below what the raw bids would otherwise have produced.

 

The Premium Stabilization Demonstration Is Ending

CMS announced on July 28, 2026 that the Part D Premium Stabilization Demonstration will conclude on December 31, 2026, one year earlier than originally scheduled. CMS says plan sponsors now have enough experience pricing the redesigned benefit that the temporary subsidy is no longer needed.

This matters for anyone enrolled in a standalone Prescription Drug Plan. The $10 monthly subsidy and the $50 increase cap both disappear after 2026. The Part D base beneficiary premium rises to $41.33 for 2027, about 6 percent higher than 2026, and CMS projects that most standalone plan enrollees will see individual premium increases of less than $10 per month.

If you are in a standalone drug plan, compare your options during the Annual Enrollment Period rather than letting your plan renew automatically. Plans that leaned heavily on the subsidy are the most likely to reprice. See the Medicare Part D plans 2027 guide for what is changing.

 

Revised Risk Corridors

Revised risk corridors remain a key part of the risk adjustment model and improve the predictability of costs for Medicare Part D plans. They limit how much a sponsor can gain or lose relative to its bid, which reduces the incentive to price defensively and keeps premiums closer to actual expected cost.

 

Low-Income Subsidy (LIS) Program Adjustments

 

Eligibility Criteria for Full Low-Income Subsidy

The Low-Income Subsidy, also called Extra Help, is the program that makes Medicare Part D affordable for people with limited income and resources. It can cover your drug plan premium, eliminate your deductible, and cut your copays to a few dollars per prescription.

Extra Help is unaffected by the demonstration ending, so if you qualify, your costs in 2026 and into 2027 stay protected. The sections below cover who qualifies and what the limits are.

 

Eligibility Criteria

To qualify for the full Low-Income Subsidy in 2026, your income must fall below 150% of the Federal Poverty Level. In the 48 contiguous states and DC that works out to roughly $24,180 per year for an individual and $32,700 per year for a married couple living together.

Alaska and Hawaii use higher thresholds. Income counted toward the limit also reflects a $20 monthly disregard, so you may still qualify even if your gross income looks slightly over the line. Apply through Social Security rather than assuming you are ineligible.

 

Resource Limits

Resources also count. In 2026, the limit is $16,590 for an individual and $33,100 for a married couple. Those figures rise to $18,090 and $36,100 when you include the standard $1,500 per person burial allowance.

Countable resources include bank accounts, stocks and bonds. They do not include your home, your car, personal belongings, or a burial plot. A significant number of people who would qualify never apply because they assume their savings disqualify them.

 

Medicare Advantage and Part D Integration

Medicare Advantage plans that build in Part D drug coverage remain a major part of the market, bundling hospital, medical and prescription coverage into a single package rather than pairing Original Medicare with a separate drug plan.

Integration often means lower total costs and extra benefits such as dental and vision. It also means a narrower network and a single plan controlling both your medical and drug coverage, which is the tradeoff to weigh.

 

MA-PDs vs. Standalone PDPs

Medicare Advantage Prescription Drug plans (MA-PDs) often carry lower overall costs than standalone Prescription Drug Plans, and many are available with a $0 plan premium. They typically add benefits a standalone drug plan cannot offer, such as dental and vision coverage.

Standalone PDPs remain the right choice if you want to keep Original Medicare, or if you carry a Medicare Supplement policy and need drug coverage alongside it. With the premium stabilization subsidy ending after 2026, standalone plan premiums deserve a closer look during this year’s Annual Enrollment Period.

Find a Plan and Enroll Online Yourself!

Advertisement

OR SPEAK WITH A LICENSED INSURANCE AGENT

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

Enrollment Trends

Enrollment in Medicare Advantage plans grew steadily for years, reaching 32.8 million people in 2024, about 54% of the eligible Medicare population. For 2027, CMS projects about 34 million Medicare Advantage enrollees as some carriers cut plans and exit counties.

Choice remains broad, with the large majority of beneficiaries able to choose from 10 or more plans.

 

When the 2026 Part D Changes Took Effect

 

Effective Dates for New Policies

Every 2026 Medicare Part D change took effect on January 1, 2026. Plans have been operating under the $615 standard deductible and the $2,100 annual out-of-pocket cap since the start of the year, so those are the amounts applied to your current drug coverage.

There is no coverage gap to worry about. The donut hole was eliminated in 2025, and once your out-of-pocket spending reaches $2,100 you pay nothing more for covered drugs for the rest of the calendar year.

 

Medicare Part D Prescription Coverage Made Simple

Finding the right Medicare Part D plan doesn’t have to be confusing. Get coverage for your medications and avoid high out-of-pocket costs next year.

Our licensed agents can help you compare options and choose a plan that fits your prescriptions.

Call 1-866-930-4039 now to compare your 2027 Part D plan options before the December 7 deadline.

 

Frequently Asked Questions

  • What is the standard Initial Deductible for Medicare Part D in 2026?

The standard Initial Deductible for Medicare Part D in 2026 is $615, up from $590 in 2025.

 

  • What is the out-of-pocket spending limit (RxMOOP) for Medicare Part D in 2026?

The annual out-of-pocket spending limit for Medicare Part D in 2026 is $2,100, up from $2,000 in 2025. Once you reach it, you pay nothing more for covered drugs for the rest of the year.

 

  • What are the Part D deductible and out-of-pocket cap for 2027?

For 2027, the standard Part D deductible rises to $700 and the annual out-of-pocket cap rises to $2,400. You can compare 2027 plans during the Annual Enrollment Period, October 15 to December 7, 2026. See the Medicare Part D plans 2027 guide for details.

 

  • What change occurred to the Initial Coverage Limit (ICL) in 2025?

The Initial Coverage Limit (ICL) was eliminated in 2025 and replaced by the annual drug maximum out-of-pocket spending limit (RxMOOP). This change gives you more predictable out-of-pocket costs for prescription drugs.

 

  • Can I still spread my Medicare Part D costs across the year?

Yes. The Medicare Prescription Payment Plan lets you spread your out-of-pocket drug costs into capped monthly payments across the calendar year instead of paying large amounts at the pharmacy counter. Participation is voluntary and you must opt in through your Part D plan.

 

  • What methodology is used for the Part D risk adjustment model?

The Part D risk adjustment model uses a multiple linear regression methodology to determine normalization factors, integrating five years of historical fee-for-service risk scores to improve accuracy.

Begin Choosing your plan

Advertisement

CALL TO SPEAK WITH A LICENSED INSURANCE AGENT

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

ZRN Health & Financial Services, LLC, a Texas limited liability company.